GlassScriptPhysician profile
Mara M Rodriguez
NPI 1518242346
$2,893.82
in general payments reported to CMS, 2019-2025
18 companies · $401 in 2025
The $401 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $766 · 2020: $438 · 2021: $464 · 2022: $367 · 2023: $122 · 2024: $337 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $859.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,121.70 | 2020-2025 | Airsupra, Farxiga |
| Allergan, INC. | $373.40 | 2019-2020 | |
| Novo Nordisk INC | $206.75 | 2021-2025 | Ozempic |
| Pfizer INC. | $199.24 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $170.16 | 2022-2025 | Nuzyra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $153.91 | 2019-2022 | |
| Idorsia Pharmaceuticals US INC | $121.80 | 2023 | Quviviq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.29 | 2019 | |
| Astellas Pharma US INC | $95.45 | 2019-2021 | |
| Lilly USA, LLC | $81.28 | 2024-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $69.36 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Amgen INC. | $47.16 | 2019 | |
| Novartis Pharmaceuticals Corporation | $44.00 | 2022 | |
| Alkermes, INC. | $39.70 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $25.53 | 2025 | Voquezna |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $24.30 | 2025 | Gemtesa |
| Amarin Pharma, INC. | $23.79 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mara Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.